Suppr超能文献

甘露糖配体用于甘露糖受体靶向。

Mannose Ligands for Mannose Receptor Targeting.

机构信息

Department of Chemistry, Josip Juraj Strossmayer University of Osijek, Cara Hadrijana 8/A, HR-31000 Osijek, Croatia.

Department of Nursing, University Center Varaždin, University North, Jurja Križanića 31b, HR-42000 Varaždin, Croatia.

出版信息

Int J Mol Sci. 2024 Jan 23;25(3):1370. doi: 10.3390/ijms25031370.

Abstract

The mannose receptor (MR, CD 206) is an endocytic receptor primarily expressed by macrophages and dendritic cells, which plays a critical role in both endocytosis and antigen processing and presentation. MR carbohydrate recognition domains (CRDs) exhibit a high binding affinity for branched and linear oligosaccharides. Furthermore, multivalent mannose presentation on the various templates like peptides, proteins, polymers, micelles, and dendrimers was proven to be a valuable approach for the selective and efficient delivery of various therapeutically active agents to MR. This review provides a detailed account of the most relevant and recent aspects of the synthesis and application of mannosylated bioactive formulations for MR-mediated delivery in treatments of cancer and other infectious diseases. It further highlights recent findings related to the necessary structural features of the mannose-containing ligands for successful binding to the MR.

摘要

甘露糖受体(MR,CD206)是一种主要表达于巨噬细胞和树突状细胞的内吞受体,在胞吞作用和抗原加工与呈递中发挥着关键作用。MR 的碳水化合物识别结构域(CRD)对分支和线性寡糖具有高结合亲和力。此外,已证明各种模板(如肽、蛋白质、聚合物、胶束和树突状聚合物)上的多价甘露糖呈现是将各种治疗性活性药物选择性和有效地递送至 MR 的有价值方法。本综述详细介绍了合成和应用甘露糖基生物活性制剂的最新进展,这些制剂用于 MR 介导的递送来治疗癌症和其他传染病。它进一步强调了与成功结合 MR 所需的甘露糖配体的必要结构特征相关的最新发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c706/10855088/7f73c7be5f52/ijms-25-01370-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验